Charfty R￿istratIon NO. 113485915C039721 Company Re8ftstratlon No. 071271011Ehgland arbd Wale&} REPORT OF THE TRVSTÉES AND AUOITED CONSOUOATÉts FINANaAL STATEMENTS FOR THE YEAR ENDED 31 OECEMBER 2024 FOR NATIONAL RHEUMATOID AmRms 50aETY NAYIOIIAL P*IELIMAT(MD ARTblRITI5 SIX LEGAL AMJ AOMIN15T41ATIVE INFI)kM411O14 Trust• MrR&th5 Mr S (olllns Mr R F￿4￿1￿•￿ Mr J Jw(twTr Profr5wr P Ti*>r A Woolf Ms C WorKI MrPF(ryt UWTIW numb 113485915C039721 Cpnpiny numb•r 07127101 lJry151•rxl offl¢• ile 3, Grov0 Business P*f* White W•ltham Maldefihe*l SL6 3LW Moorn Klhvtm Smlth lip Th• ShIpp￿t WhJlfi¢ Th• Old VITr￿ Faetory 8lyth llo•d U83 114A HS8C JS Hl&h Siy•¢l M*ldenhe•d RNWMATOID ARTHRITIS SOuFrY ¢OI¥TEv Trw1tt5' report Stri1[T￿l olTrLuws' rtSPQDslbSlitlB5 45 to 6ithur¢ ty pur 14 irvjqppndent tewE Cw5plldated Sratsft*fti ol kn•TrFlol idlv*lES' 19 Cpnwry StaterMAt ol ATr•rrW K¢l¥kn5 Cwbspndi¢*d arbd CaAtyWlV 6•knncy Slkttt5 CpnsgW•t*d st0￿men1 ol Flvws 14ot*¥ IV 13-37 NAfioNAL RHEUMATOID ARTHRIT15 SOaETY TRU5TEE5' REPORT (INCLU0114G DIRE￿oR5, REPORn FOR ThE YEAR ENDED 31 DE￿MBER2o24 The TiLssle*s presènt thÈiY tÈport and auditÉd tonstsl#latÈd attounts for the year Ènded 31 December 2024. The Trustees hbve adopied the Pfovlslons of thÈ StstefThent of Recommende PracriFe1SQRP) "*(oyntin3 an¢ BeponinE by Charille< IFRS 102) ID prepiriThs annual r¢wrt tsnancijl 5tatenEnts of the Charity. The accounts have been prepared In •ctoYdar•Ce the acctsuftiinÉ wllcles set out In nvte I to the acc9unt5 arKI x)mply wllh tbe Charity'5 8overnins dowmeni, Ihe Chariti¢s kt 2011, thè Ctsmpbnies Act 2(YJ6 and -Accoun1i￿ and Reporting bv Charities: Statement of Recommènded pra￿te applicablè to ctrKaritie5 preparin8 their accounts in acco¥dante with Flnantial Reportlng Standafd applicable In thÈ UK and Reputs1￿ of Ireland (FRS 102) (effetlivÉ Ljantsary 2015 a5 updaled in 2019).. Chales Report A w3 rm w@Icome to the NRAS annu31 report on behalf of the Board of Trustees. l am very pleased to report another successful yèar with Si8nifrtaht proyess In several directions. This is entlrely due to the dedication and Pfofesslonallsm ol Ouf team, both stalf and volunteers, whose hard work ofi behalf of all those livin8 with Rheumatoid Arthrltis IRAI and Juvenile Idiopathic Arthritis (JIAI has rnade a real difference. I thank you all on behalf of the Board. Flrstly. the Board welcomes our new thief Executive, Peter Foxton, who has taken over from Clare Jacklin followin8 her retirement after many years of servlce to the charity. Peter joined us in the Summer of 2024 followlng a rigorous sele(tion proce55 and brings a new perspectlve on the challenges we and all other tharities face thanks to his relevant experience in the sertor, latterly in income generatlon for Phyllis Tuckwell Hospice Care. Peter has 'hit the 8round nJnnin< and Is already makin8 a real impact, not least In the preparatlon of the new NRAS 5trate8y. This key document, whkh will guide ovr diredion over the next few years, has been based on extenslve consultation acros5 health caro professionals, our beneflclaries, volunteers and member5. as well as wlthin MRAS ftself and wll I be issued later thi5 year. Nationally the need for NRAS'5 service5 has never been 8reaÉer. The pressures experlerkced by the NHS have resulted in challengès a¢ross the board afid the impacts on theumatolo services, in terms of access and responsivene55, have been 518nificant. Our expertlse and atient-focused approach can Gomplement NHS 5ervi¢es ¢hrou8h the prov15ion of Inforrnation and support to both the newly dlagnosed and those who have been livine With RA or JIA f4r thahy years. SÈr￿1c*s such as Right Start. SMILE and the Helpllne ean make reèl dtffÈrenco to people'5 OUtcome5. NATIONAL RHEUMATOID ARThRI￿5 50CIEr TRUSTEES, REPORT IINCLVD1fv6 DIRE￿oRs, REPORT) Foft THE YEAR ENDED 31 DECEMBER 1024 FlThincially, this has been a year of 50Jid performance. As predlctejEcttYe5 arKI a¢ii¥ltJ*s The obhects Cjf the Cha rity (the 'ObJerts"> are for the publlc benefrt ￿ promote Ihe relief of people Ikwlrf wilh R￿uMat01d Arthriti51 RAI and Jurfenlle IdlopathK Arthriti5 IJIAI by.. Raisins awa reness and urKlerstondlnE of RA and JIA, includin8 awareness of the severity of tl ¢i5eases and their social and economic costs: Providlrtg information on RA and J14 includin8 Inlorm3tlon on iheir treatments ènd drugs awa11 able; Adwanting all aspects of the care and treatment of RA and JIA and the man4ement of ihese diseases In their tofality,. Providing educatlon on Ihe di5ea5es 6eneralty and to Indivlduals and thelr fathllles arnl (areT5 in all aspects of RA ar•d J1& includin8 thelr treatment and rnana8emeni, and prowpdin8 inforniation aboLFt avall8ble support. SuppDrtiw individuals acrogs UK in relatlon to RA and JIA and their familles and urers, intludin8 pulling people In iouch with each other to encourage sell-help and support where approprbate,, WorkinE alon8Side NHS rheumatolo￿ health professiona15 across the UK to provide the best Ca￿ for patients as well as support the cJini(al stafl in their role& (￿r ¥ision and purpose 0￿r vtslon Is a future Whe￿ everyone with RA and JIA can thiiwe, Our pvrpD5e 15 to inlorrn and support people with RA and JIA and campaign for improvements io care ar•d tre3tments, We will achieve our ws•on by locusin8 on fgur rn•ln areas of work; Inform1￿ and Educatin8.' To greatly Increase underslanding of RAarNI JlAand numbet of people accessins our servlces S4JPPDrtin8 and Empoweri￿. to support more people to safely 5elf-rni n48e their health by improvin8 the relevancy, •ice551bility, vlsibility and reach of our serwices CampBlgnlng and Researth: to 5UPPOrt fÈsÈarth and rampal8n to impme aco55 io hl8h quallty carè •Thd tréètment5 Ralslng furK15 H rbd bullding a fèsil•ent 0￿￿niSatIon. to build a strong orsonI￿tIoTr ihat raises more mprEy from dlversÈ Stsurce5 lo meet the needs of paiient5 Our prlnrlwl Jctlvltles We are comm itted to prowpdifit *upport, e￿￿enced-b&sÈd I￿￿{matIo11, 5eNlces, edL*atiofft. Caftlpaignins and paileftt advocacy of the hi8hest 9ual¥ty to, on behaFf of all, thosÈ affÈ(tEd by RA nd JIA i(rosS the UK as well a5 their familiÈS. We a159 SYPPOrt health pr0fÈ5SiDr￿ts in Ihe fleld of I1￿uMat0108Y and primary (ale th1o￿h thE provi5ton of free Hèaltkare Prpfe55ional rnemborship ol NATIONAL RHEUMATOIO ARTHRrt15 SOCIETY 7RU5fEE5' R£PDRf IlNCIUOIN6 DIRECTORS, REPORT) FOR THE YE)J4 ENDED 31 DECEMBER 2024 OurfrfJnt.Ilne sÈrvicès inFlwle: A HÈlplirt* Yihi(h operates 30 hours per week and Is Martag￿ by a team of four telPwuèl' An onllnÈ pepr 5UPPQrt community Local and virtual £roup5: A peei.tts.ppÈr telephone support programme: A supwrted self-mana8emenl modular ¢-learnlTr8 pro8ramme' Informatitrn booklpts. WebsitÈs packed with information and downloadable resourto4' PatiÉfii èvertts It￿th in person and virtually} A membèrship xheme Living wrth RA and JIA is not jusl about havln8 physical and medlcal needs. These incurable dlseèses have a huge imw on emotional vrellbeing Ind qvality of Ilft ¢M both the in4Jividual an(f t￿rr famity. We will continue io strfrve lo help peopk by suppori1￿ oll their needs In a holistic way whether phy5i(al. medical, emotional, mental, soclal. econornic and/or eff•plo¥ment related needs as well as thos* relaiiw to access to beThefllS. We are èt ihe tabk at a nat5on&l level whenever standards and guidelines WJIA pathwaysand access to treatment are bein8 dtscussed, We conduct our own S￿la1 ￿searCh and publish k¢y reports on • topic of importarKe to people w¥th RA/JIA perlodlcally. Tran51alional scleniific arKI medical research h•$ revolutionised the fleld of autfrimmulle condlthjfis h as RA and JIA in the lasi few decades and whilst we do not fund mÈdical research oursel¥es. we do SUPPDrt a Erowiw nufflbe¢ of atadÈM•c and clinlul researth stud￿5 thrO￿hOul UK on an Ollgoin8 basls. We also support fecruitrnent to clinical studies and provide txpert VDlunteers to advlse on issues ol Patientand Publlc Irwofvement. We do on o(cas•on conduct our funded major social research slud*s often In partner5hlp wlth an academic Instiiuie. In 2024, we continved Ehe deveh)prneni of our suite of e.leamln8 self.management programmes, dev15ed and prDduced by our fourmler and now National Patieni Champion, Ai15a B05worth MBE. WE ha￿ a total of Seven modulés fiÈély available for anyone to acce￿ on our websile arbd work h45 now started on OLpr largest a nd most complex module to date, Cardlovascular Disease Risk Mana8ement. In 2025 we plan to start WQfk on de￿rning a range of short vldeos to complemenl Ihe modules already avallable. These VTrdeos will aim to present thÈ key his￿1¥ht5 from of our mcKlyle51Tr In informallve way and will accesslble on variety (Jf di811•1914tforms. We a150 plan to run an awareThe55 campaign fo eniourage even more health professionals to utili5e the SMIIE modules for patient edu(i lion by signposting people liviTrg With RA to register foi the progfammè. NATIONAL ftHEUMATOID ARTHRrnS SOOETY TRIJSTEES. REPORT (IIICIUOING DIREcfoRS' REP( FOR THE YEAR ENDED 31 DECEMBER 1024 Nrf Income totalled over£l.$4ffl How we raised our money £n8.Th £45J.4 £22S.9k 11 £59,Ik 00N￿> arrfl lifts Clwiiable •ctfvths Oth•r Yxoffl• • 102J • 2014 11 was gothg ts b• • Ch* to ropkakn *t a)corn• i•v•ls a￿j w il Dv•d 10 b• with over•1 wKorM dcy*n 17.5% ￿ 2023. The yearfs perforniance was 48•ln dofflinated by legacy bequests where reported Incon* ￿l¢l￿d £788.7k, representiw 0￿1 51% ol the Charivs total income. Whilst this rewlle(I le8acy IncorTre wa5 a drop of ovtr 2496 on pnor ye4r li vi45 ￿111 our secorKJ-be5t lesaw perfomiance ever and rpflects the trend we have seen in recent years for larger individual beqtsests. We tEtnain immensely grateful to our very Benerous bÈnÈlattots whose gifts enablÈ us to coniinue to lftvest in Our servTce5 and deljvei new irtrtOvation5 which are 50 needed especialty ès we Ènièr a hèalth environment rr*O(e focussed on deliverlD8 servkÉs dpgitally. Irptons and partrbefships knITth pharmaceutical cornpanles ta¢pfully and work ¥vl*hin thÈ atcepted wde5 of practiCÉ SÈt down by Ihe A550Clation of thÈ BritA5h pharMa￿uL1¢al lTrdu5try IA&pi). As well as hèlping to fund the cole serwitÈs that v*e deliverfo our bernÈficiarie5. Ihese relatlonships Pri>vide NRAS wlth access to irtlportgnl jnforyDaiion I boui clinital trlal data arbd hÈlp tts infvrm an¢ edu￿te otsr team membe[5 on RA and JIA, AS a keyexFYrt partner NATIONAL RHEUMAfoiD ARTHIUTIS SOCIEr¢ TRUSTEES, REPORT Iit4CLUDIIIG DIREcfoRS' REPORn F(￿ THE YEAR ENDED 31 DECEMBER 2024 NRA5 conEribute5 to advisory boards ahd employee iralnin& as WÈH as PTovidln8 SUPPOrt In the de¥e￿pfftent of their Own patienl-tacin8 5UPPOrt rÈsources. The Clbarity also operates a mÈmbèTship Scheme for those Ilvifit with RA or JIA their famllles and health care piOfÈss￿n3[S which provides access to a mernber< forum. monthty new5Petters and a b anp)ual magaiirbe full of intefesiirrf article5 and informatlon. IntomÈ from the membership Kheme totalled £81.3k In 202412023: £85.4k). Support for NkAS wès al￿ rècewed thro￿h 8lallts from trusts and found3tiorFs afid in 2024 thll amountetl tel EID5.3k (2023., £72.6k), répfÉ￿rttlntt a 45% increase. We V4Ould like to expre55 partitular tharbk5 to the following organisations who all donated £2.(XK) or over: N&t10r￿1 Communltles Loite¢￿$ Fund Awards for All Ewlahd. National Lottery Community Funcl. The Plational Lottery - Award5 for Ail Scotland. Edith Florence Spencer Memorial Trust, The Frank ￿t(br*I￿ General Charitable Trust, The Millenium S¢adlum ChartiablÈ Trust, Th¢ February foundat￿, The fjrKe Trust, The Vande(Yell Foundatlon and The Eveson Trust. We continue to work with aiademic partners, phlmiaceutical cofflpanles of ot￿¢ oi£anisatiOns i the flelrl Df social research to help dévelop and deliver new servlces to best meet the need5 of all Ih05e we serve as ¥véll as campai8n to effect change wlih governrnent. the NHS and thDse who commiSs￿n healih and Social care service& In 2024 income 8eneraied from research activilies toi•lkd £16.Ok {2023: £29.2kl. All lTrcome receywed throu8h furKlrak51ng In 2024 contributed io enablln8 the Charity to provide a full P(QEramrne of resources, Ictivitles and support which be￿ffits those living with RA JIA In the UK. their families, schools and the healthcare pr4)fessiOruls who care for them. NRAS w¢uld lik t acknowlèdgè and thank all the Indlvlduals. companies, trust5 a nd loundations that have supported our work this year, NAnONAL RHEUMATOID ARThRms SOQErY TRUSTEES. REPORT IINCLUDING DIRECTORS. REPc￿￿ FOR THE YEAR ENDED 310ECEM8ER 2024 T1￿ expendltufe totolled £l.57m (heral ex[￿nthr• yOOf weag•d ty 2.9% ￿ £1574m. Of lh* total am￿rt £304 7k w spthit M raising funds to £348.Ok ￿ 2023. A total 01 £1.269rn (2023", £1. 182m) was swrd Money spent on charitable activities f438.0 £385.4k UJO.2k £1￿.4& £71. 11 people •202J • 1024 Avern8e full.tlme equfvaleni employee rwmbers totalled 26. urKh•n8ed Since 2023 wlth employ￿nt costs I￿n& by 3.2% reflecti￿ an￿•1 c051 of Il¥k¥ Incr*ase5 awarded to all sthfl. The Ch•rty rnported a con501bdatereseeable fvtwe. NAfioNAL RHEUMATOID ARThftITIS S￿Ery rRU5tEES' REPORT (INCLVOIWG DIRE￿oR5, REPORTI FQR THE YEAR ENDED JI DeCEM8ER 2024 F￿ndraIsIn£ pra¢11¢￿$ ThÈ tharity complles With thÈ re8ulalory sfandayds for hjndra i5iry. We are rÈÈisterèd with the FuThdraiSine Regu13tor arbd are comfftitiÉd to the FundralslD8 Promise and adherence to the Code of F￿nd[al51￿8 Practi￿, Thls report covers the requirements Iharitl¢5 111115t follow as set DLIt in the Charif*es Acl 2011 and the ¢hariiies Social and Protettion 2016, Our fufidiai5ing effort Invofves Ér￿ur￿inE donations through a variety of events, apolyihg for fund5 from Erant-rna klnE bodiÈS vperatin8 a weekly lottery. Our ftyndralslng tÈam tofnprise5 paid employees only and we do nol use ihe Sèrvi￿5 of èny pr4)feSsio￿l ￿nd￿lSer5. ￿1 dlrect marketins Is tsndErtaken by ihe fuftdraising department to eftsure that il is not unfeason4bty intrusive nor petSi5tent, All rn3rketin8 material ffjntalns clear instruction5 on how & person can be removed from malling li5t5. We operate our lottery compliantlw under licen￿ from our local autknityand all admlnlstrauort is handled by a certified Exiemal Lottery Marw8er wllh the Gathbliry Comrnlsslon. OtJr website outline5 Ouf complalrtts policy lor the publlc and clearly explains how an Inillvidual carb Complain. We received no complaints thts year lft ¢*lation to fundrats4n8 artivlllés. We have published 04Jr vulnerable persQns policy on our websire. ITr addition to our poliry we hlve aTr agrttd operaiin8 procedufe to Pfotect vulnerabSe people. Our fvr)dfaisers. who are all paid employet5. are familiarised with ihe code olconduct to ensufe that it 15 appl￿d properlv. Invtstnient Polky •nd Oblertlves Longer.ierni isseis afe irwested wilh ihe alm of ai ￿ast maintainlry the real value of c3pltal11.e. a8alnsl inflation) within In appropriate risk Profile. The Charlty's investment obJeclive5 ore to invest lor the Ion8-term Ifive years plus> in a diverslfied portfolio en5urin8 that there is sufficient liq uKlity •￿il#ble to fund any 5hortfa115 or unfunded commitments. Investment5 are rnonaged by external professional fund manager5 3$ permilted by the ￿levant a(t5 ¥nd the charity commission guidelines. The Charity aifft5 to be a responsible investor and Ils professiona l fvnd managers are expected to take accouni of Envirtsnrrbental. Social and Governan {ESG) i55ues In thelr ihvÈstment analyst5 and decision*rnakin8 protees are briÈfÈd on their legal oblisatlons Ufbdèr Chafily law. the content of the constrtLJt afid d*tiSiDn-makin6 pr￿e$s. tho business plan and recent financial perfom)ance ol ihe Charity. A5 part of the process they meet key employee5 and other Trustees and may atlend addit￿nal, relevFJnt eKtemal trarnin$ a5 re9uired. Ory•nlsatlèn ThÈ ￿dY of Trustees conslsts of not fèwer than four and no more thbn t￿￿1¥ ifuStèes arK4 administeri thé Chi¢ity ih[ts￿h the Senior Executlves. Re14ted partSes aYKJ fov0￿ration with other 31 DECEMBER 2024 Auditor5 In actardance wifh the compaftls artlclès, a re501ution prowsin8 thai MoorÉ Kingswn Smith LLP be re-appoinied as atsditoraf the CDmpany will be put ot a Genefal MèÈtin8. Trustees. r•spoThsibllitie5 in relwtton to the fln•Thclal statement5 The Tnjsrees, who are also the direttor5 of 14atk)nal Rheumaioid Arthritis S￿iety for the purwse ol cornpany law, are respon5trble for preparing the Trustees. Report arhd the accounis in accofdanc wilh applicable law and United Kingdom Accountin8 Standards Iurtiled Klngdom Generall¥ Ac£epted AccouThtiw Practice). Company law requlres Trustee5 w prepare accounts fof each finanoal year which 8ive a true 4Thd fairvlewof the state of affairs of the charlly and of the incomiry resources and applitation of resourre5. includin8 the Ir*toft* aNI expenditu￿ of the charitable ¢ompany for that yeir. In kKepari￿ these accounts the Trusiees are requifed to: Select 5Ultable accountlng policies and then apply thern c0ns1stènt￿, obse￿￿ the methods aThd principles in the Charities SORP IFRS 102): Make jud8ments and esiimaies that are reasonable and PTudenL' State whether applicable VK Ac¢ounlln8 Standards have been followed, subJe(t to any miterlal depafture5 disclosed and ewlained in the fiThanclal staiement5: arbd Prepa re the accounts lin tht going concern bèsis unless It Is inapprowiate to presume that tho charity will continue in operatlon, The trustees are ￿ sponsible lor keeping adeq￿te attountln8 records that di5cF4Jse with reasoriable curhcyal any time the financial posil•on of the charity and enable them to ensure Ihat the accoun15 comptywirh ihe Companies Act 21VJ, the Charities and Trustee Investment Iscotlandl Act 21XJ5 arwj ihe Chlfities Accounts IScoikThdl Re8ulallons 2006. They are a150 responsible for 54feguarding the assets of the charlty ond hetKe fof taking reasonable step5 fof the prevention and (J@lecE•Dn of fraud ind other irregularities. The truStèÈS a￿ ￿5p￿rIs￿b￿ for the mainteThaThte and intesrity of the c4rporate and finantial nformation Included on ihe chaTitable compan￿5 website, Legislalion in the Unsted Kin8dorn 8overning the preparation and d155emlnation of financial staternent5 may differ from legislalion in other jurisdictlQn5. NAnONAL RHÉUMATOID ARTHRITIS SOCIETY TkUSYEÉS' AÉPtsRT IINCLUOING DIREcfoRS' REPORTI FOR THE YEAR ENDED 31 DECEMBER 2Q24 stpi¢menl •¥ to dlxlc•yJ*e to èur auditOf5 In SD (ar is rhe trustees arè a¥•arÈ at the time of approving Quf TTUStees' Jnnual iÈportr. There is Tro relevant inforlnation. being inlormatlon needed bv the auditor in &)nnÈctiO With prtpafing their report, ol which the 8roup'$ auditof is unaware, and The tfQStees, having made enqulrles ol felbw t¢uslets and the group'5 auditor ihev OuEht to have lTrdlv•du•lly takÉn, havé Éèch taken a115teps that bel sh¢ h5 obll8ed to take as a Irusree, in order to make themselves aware of any relevant audit infowmation and to e5t3bli5h that the iudllor Is aware of Ihat irtfofmation. The ifvsteés aré responsible fgr the malfttenonce and inte8tity of the iorpor3te ancj finandal intswmalion included on the charIlab￿ tompany's website. Legislation in the Uniled Kln8d&m 6ovemln8 the preparètion and di55ernination of financial statements may differ from le8islat•un i other iurisdictDDns. S Collirts c￿air of Trustees J Jotdaft Treasurerl Trustee NATIONAL RHEUMATOID ARThRins SOClEtY YRUSTEE5' REPORT {IPICIUDIN6 ts1 kÉttORS' REPORn FOR THE YEAR ENDED 31 OE¢EM6ER 2024 Oplnbn have a4Jdlied fthan¢i#l sl*ment5 of Nallonal Rh8tsmalthd Arthntis S(Kiety {the 'p¥ent charilablÈ Tr)ryany') and its subsidlary 'gtOup') fr>r Its yew ended 31 D￿4￿M￿ar 2024 which (wrlse Il>e Consolldatèd Ststerywl of Financial Actlvltltt, (irtludin9 the Consdid?ted S¥mmry IncomÈ 8nd Expendrture Accotsftl). thè Grtsup and Parent Charitable Cornpany Balancè Shèèts. iP ConsoJKlaied Stalèmmt of Cash FI￿￿3 and notes to Ihe flnanaal &tsteffients, induding 9¥n￿cant atCOLtnb'rtg ptslic>ps. The financial reporting Irarrtework thal ha5 tjeen applied ￿ Iheif wepara1kJn is p￿￿rable Faw and Llnrtéd KirtQdom Accoun￿9 Standards, Flrtancial Rewrfin9 Standard 1 The Financial Reporting Sta￿￿ard appii¢abl8 in UK and Republic of Ireland (Untted King¢Jom Generally Accepied Accounting Pract￿e). ID our opinion th8 fiftancial $taÈw*nts". rve a true and lair vh7w af thè sEal• ol Ihè )r￿P,$ and th¢ parenl charilabl• ¢ompaty'$ affairs aB at 31 DeCèrn￿r 2024 and ol the group's incoming cesourtes ond aPpkati￿ ol resour￿1, Ir)clLKfiry its incon* 6XPèhdrturè. Ihè yèar Ihen e￿Jed. have been propefly prepared ￿ aCcorda￿e wilh United KlThJdom tsèftéfaty Ac£eptsd Aceountiflg Prac￿￿, and havè bèèn prepared in accordance vnth the Companles Ad 20￿. ts Charit*s 4nd TnJsi•8 Iryvestmenl {Scotland) Aet 2005 {as athènded). re9ul8lions 6 and 8 01 th• char￿8* Accounls (Scouand) Regulalions 2006 las amendea) and thé Charrt)ès Atl 2011. 8a81• lor oplnlon e coTrducied our audrt In accordance with Internat￿• sianoaiés on {UK) IISAS (LJKI) Bnd appk4tA8 law. Our respons￿111￿.es under those standards are furthL¥ descnbed in tho Audrtorf$ Re3F4)n*￿Illie$ lof ihe audrt of the fmancial slatements sectt)n of oui re[￿l are indÈpendent of Ihe Gh¥iiabfe conwany in accordance with the ethical requirements 8re relev8nt to (Mjr audrt of th• ffinarwl Statements in the UK, IrtludirvJ the FRC'5 Eth￿1 Starhaard, and we have fuini*d our other 81 responsI￿tEleS in aGG0rdan￿ Wih these reqvJr•ments Ive L*beve that the wdrt ewdetKe have oblained i¥ ¢ufvSpffli 8nd apFKopnate to WOVKle a basis fry our O￿n￿Jn. ConcluBlon• r•l4llng 10 goSTrg Gonurn In avdilir*g the fingnci81 *t¢￿*￿ts. we have concluded that the trustees. uae of the swjins ￿l￿ern ba618 of wJuniiry in tho prepatstson of th¢ fin￿¢1?1 staipmwis 4$ appfoprlats. Based on the work we hawa wrformed, we hpyg nol vjenif￿￿ any rnateftal UnC8f13inlies robting to eve47ts or condilrons that, indiv￿UaIty or collectlvety, may cast s￿nIfiCp￿I doubl on Ihe group's and parertt ch8rrtable company's atsllty to continue as a goir¥ concwn for a perb)d ￿ al lÉast t**l¥e nK>nlhs from when Ihe financial sl*ment5 are authonsed lof issue. I￿r reswrbsibilibès the Iw￿¥1￿.11ts.eS ol the Iru8te•s wth respèct to g)in9 con¢errb a￿ degCTiberS in ¥p*Yant seclions 01 thls r8pofL Olhèr InfDrnl•tlon Thé othw intsrrnptic>n comprtses the Inf0m￿liOn inthdÉd in the ?nny?I report oih8r than the finantial stslements and OUT auditorfs rppcKI thereon The trustees are respornsible ts Ihe ot*yeT inlornkBliOll Otltsinèd in the annual reporL Otsr opiThlon the finangpl slptemenls does nol co¥or thè cthèr nlDtnation and. èxeèpl lo Ihe pxtent otherwlse explluty slated In our re￿r( we do n(* ejprpsg any m tsf CAy)clusion Ilwoon. 15 NATtONAL RHEUMATOID ARThRtTIS SOCIETY TRU5TEE5' REPORT {INCLUDING DIREUOR5' REPORTJ FOR THE YEAR ENDED JI DECEMBER 2024 Ouf rèad Ihè othér ￿k￿rnat￿l and. h) dem￿) Èo. whé￿￿1 thè Offtéf t]rrnHIiDn iy m¥teriplty inc4yt5i5tenl wilh Ihe tr￿￿1a1 staiemeTrts w ¢Jur krhJwl¢dge obtsined in Ih urse ol Ine audrt or Oihep#ise appeafs io be rnatulially ml$staiÈd. If we Klèniify SL￿￿ mai8ftai Ir￿n￿en¢19S or apparpnt material mi5state￿￿nts. we we required lo 4JetPfmine wheiher there iy M£￿[181 M￿StateMent in ihe finan￿1 statsments themsefves. 11, bagéd on thè w￿k w8 pèrfonii8d. WB thHt Ihw? 15 8 mBterial mi55tstenwnt of thiy otr*r infonnBD'on. we are iequirpd to thai raci. We have nothing to fepNt Irb thts fegard. Oplnbons on oth•r matters prnscrlb•d by th• Companl•s Act 2006 In otsr orAnion, bas•d on work Uftd8rtakén In tho ¢A)vrs& ol thè audlt., Ihe information 9Nen n the truglees. annual report fw the financial year ft)r the finanGial Stat￿ents are prepared is conststènt fIn￿C￿l staiements,. and p trustee¥. annual has been prepared in acwidwKe with applK4bie kga] reqU￿￿￿nIS, attorn vn whkh wp arn rn4uired to report by exGeptton In Ihe light of Iha knowl&Jge and understanding group and p*Mt ¢hartsbla cornpafty and the onvri￿rnenI Obtair￿ in the courde of the audit, we have not idenirf*•J rTratef￿1 misststements in the trLrttth$' arMu¥ reporL have nothing to r•F)Ort in rnspect of the foll￿1r￿j mallws th• Companiès kt 20(￿, the Charit*s Accounts {ScollaThd) Regula￿￿$ 20C6 (as an￿￿Je￿) an¢J Ihe Charities Act 2011 require us to reptsrt to you rf, in our p¥ont Ch¥ti3b￿ comparry has keN adequate arKI s1ffK￿t x£4wllng reC￿d9, or ieiums adequate lor audit have not been rec•i*AI from branches I￿4 vlsll•d by us" or Ihe p8renl charilabk companys financial stalements we in a91•omenl wbth tha accouThVn9 r•cords and returns,. or certain di8clo5ures of truste•s' r•mtsnorat•on spxifièd by law ar• not rr40o: we have receNed &ll the and explana￿0￿$ we rewire tof Ouf audrt,. or the trustees w¥e not entrtled to prepare the finarKial stslements in accordance with the irnll corrpanitis regrn and lake •dvanta9e ol the sTro11 cwipan*s exeffloKn In preparing 1 *A4$iee$' report and trom we6wiry a straie9K repo(L Rpgpormlblllgles of tr￿￿te•8 A¥ eKplgined rtxye fvlly in Ihe trustees. ￿9p￿SibIl￿￿S statemenl sel Out on pagè 13. thè Irustees {who am also the dirèctois ol the charitable company lor the Pufwses ol cornpany lawl are Tesponsible lof prep¥alton of the financ￿1 5tsteNEnts belng sati5fiens. or h4ve Tro realisiic altem1￿.¥8 but to do 3Q Audltots R•Bponglbllrtle¥ for the •vdll ol th• flngn¢lwl rytstoffjom tye have been appointed 85 auditor Secb'on 44{1 Mc) of Chpaitie5 and Truslee I nvÈGt￿￿nt Isttooand) Act 2Q05. Companies ACI 20￿ and S*dJon 151 of the Charn*s Act 2011 aTrd YrNJ in a￿ordance wth regulaiions made unde( those Act5. 16 MATIONAL RHEUMATOID ARTHRITIS sooÉni TRLisfEÉS' REPORT {INCLufAN6 DIRECTOftS' REPORn F¢￿ ThE YEAR ENDED JI DECEMBER 2024 {￿r Ire to obiain rèasonabte gyJyrance about whtthèr IhÈ f￿￿claI 5t¥lements a5 a wh are IrÈé Prom rhatenal nkt55t4iemeni, wnethèr duè ID ftaud or eftot, and to wue an auJitors tetjort Ihal h)dudey (wr opinion, Reasc*nab5& assurance is ¥ hBh level of assu¢an¢é. bu1 is ngt g 9ygrEntep thai an dkl cond(pCtèd in attcwd4ryn¢e Wilh ISAS (UK) wlll ahyays de*t g m*rial Misstaten￿nI when rt éxisls. Mis5tatpmEnt5 can arise Iroth fraud tsr orror are matefiai rf. individually in Iggr4ats. they Coulcl rèasonably be expetsd io Influence thè e¢onwwG ￿￿1$1004 of u¥ers taken thè batsi5 of IhesB final￿1￿1 slalements. At of an 4udrt In accordarté with ISAS (UK) we exerclse prolttslonal JLKIGen*nl * rrpiniain professional SCePb¢ism throu9hout the audL Wé also: Idenikfy and asséss ts risks ol rnalefial misstalemefit ol IM hnan¢ial $talw*t￿, Wh￿tI)er dwJ ta Or error. design 4nd perform audil procedufes responsive to Ihose flsks. and obt8 audlt evKlence Ihat Is SuffiC￿nI and apwopn8te to ￿0¥￿Iè a basis for Quf opinion Tr rLsk ol r•Di détecting a misstatement rèsulb'ng from fraud is higher than for one resumih9 fTc>m ror. ag fraud may Involvè colluwn, tsgery. intents'onal onwths, mi$opre5eniBlions. or the ovérnld• of ￿ternal c￿trOl Obtain 8n uftd•rsiandln9 of intemal control relevanl to ts audlt Its ordey to deg￿n audit proced￿re5 thgt are appropriate In the orcumstances, Iwt r)ol for Ihe purpo8•s of èxpf8ssEiig on the ell•¢tlvertess of the group and parent ¢harhabl• ¢empany's irtorn81 GoThtroL Evaltsalè thè tpproFYiateness ol accounting polK¥es Lued arKI the r8asonatrAené&s or accounbn9 esllmaltt and related thsc103ure8 made by Iho trusteès. Coneltsdè e>n the appropriateness ol the twstees. use of the goiTrJ concern basls of *eounlln9 and. b88ed on thè aLrfJIi évrtjen￿ obtaiThed. whether a rrotefial urKerlainty exists reLthd tr) events or e<4nditiMs that 819nrf*anl doubt on Ihe group and pafent charitablg company's ability to co￿nue as a goffig concem, If we conclude that a hlalerial uncertainty exisls, we ar? required to df3W attentlon In Our audrtorfs tewrt to the relaled disclosures in tho financ4al stgtemenls or, Il such disclosures are in•dequalÈ, lo mcKJify Our ownion. 04r conclusions are based ￿ Ihe audrt eV￿enCe obtained up 10 the date of 4Jur 3udrtoV$ repo Huwever. fulure events or conditions may c8use Ihe wp or paTenl Charita￿ company Gea5e k> contsfi￿ as a going conGem. EVaIL￿te the r)v￿alj pr•s•n&ttin. Struciure and ¢ontsnt of the IInanc￿ ststoménts, inthdin9 the dkscbsw•s. and whether the fina￿lat s¢alements f•w•s8nt thè undetying tsws&tK)ns arml •¥enls in a nKqnner ihai ac￿¥15 far wesentstion. Oblan sufficient apprDprwte aLKJrf evidenc• regarding thé fina￿181 Mirom￿ll¢n of the busitie5¥ ￿Vrt￿3 wdthln the group to exp￿$3 w opn*Jn on Ihe conS￿dated finana81 ¥i&ternents. ￿ are responsitrAe fof the direaion. sup8r¥ision and perfiymwGe QT the gfoup audil, Wp r¢rnB￿ solety fessx)n&ble lor our audit re￿)[L Wtr communi￿le ¢ho%e thargeé with 9oYemanGe Ip9w¢I￿g. ?mw9 Other mallers. Ihe ￿nned cope and It'ming of Ihè audrt and S￿￿[r￿￿nI audll findsngs. Including ￿ swnrfr4nt defveThxs in Irbtemal conlroj thal we i(lentify duri09 our audll Explamatltsn as to what exttnl th• audtt wat eonsld•rad ￿41p￿￿1• of d•ts¢tlng Irr•gLrlarill*&, IncluJiTrg fr4ud Irregul4ritips, iTrcbJding fraud. lftstsnces of nonrycwpbance wllh laws and rÉav1atit￿s. ¥IVe pwocedurés in linè with oyr regponybtlities. outlinèd aboYÈ. to dEI* materi* mi55taiements In rÈÈpÈct of irwvlorities. l￿dud1n9 Ifaud. The exlpnl ¢0 which our Pr(￿lures ar8 C¥*J* of d￿e0￿￿9 regU1arrt￿$, iftcluding frBu¢J is detaiÈd below. Th& otJi•ctrvÈS Ot pvdil 111 respect ol Iratsd. arè. to idÈlltty Bnd ?*gess the risks of matérial rrti&stslewt of the fina￿la s&tèrhèrtts dup fr4wJ; to obtain Sull£￿7t a¥4)rO￿.* gvKleFb 17 NATIONAL RHEUMATOIO ARTHRIT15 SOCIETY TR115tEE5' REPORT (I NCLUOIIIG DIRE￿oRS, REPO8TI FOR THE YEAR ENDED 310ECEMBER 2Q24 wegarding th8 aSSèSS¢d ri5Pfs gf rriatorFal miSstste￿￿nI due to fraud. throu9h 2.> 49. LIIL9 Yolal r•H￿rE•s 1.$38.1 741 *4et belfft lrpltstff￿rts 13LI> IL41 132,51 33￿0 3XI rAO Gvo5S tr•rnsf•r% bttw Iw 0.0 0.0 oo oo Il¢t lur* 27A 40J.9 11 i Lg)7.4 2Qa L5￿1 11.51 19.4 L5 L613.5 0.0 I￿23.3 IW.4 ?￿17￿ Thi hWE5 13 ￿ IF f4XM Pwt ofthw 19 NATI(￿L SQ (. J I.t10&5 1.131.3 IJIFIA I,1)1,3 IP71, Cuf¢*ni *SS•t5 Debrors 1$ 129.0 161.5 611.0 132,1 261.5 617,6 0.0 667.4 •t ￿ttIn IJX18.5 lJ)71.2 LU71A, u•￿1￿1." Q•drtor5.' fallkn$ witlaTr on• )wr 17 197.41 (125 2> 197AI 1124.71 Net t4¥rw* 911.1 913,1 T¢l•l etsrrent Il•billtI•5 lJ>17,4 2M6.1 1,020.1 ljnrtstr￿Cttd fwb¢¥ estrirted Fmds 19 19 1023J 20,1 U97A 20.Q I,oz 2Q,I ILMI 2.043.4 017A 2,O46,1 L020.1 The Tntstt•5 Iwvt we￿red •ctounts in x¢Ordan￿ wlth se£tth 39101 the Cefflp•n￿ ILt 2IJKs Imd s•rtlon 13101 the cl￿rItieS A£1 1011 and rDTrllliufe the aNn¥al r•qUIr￿ Comwnles A£t 21ty26 4fid irè ¢knil*iion to trustees ol the cornp•rw. Tl>M are prepfi￿d In att￿dI￿ wlth IhE sw(lalwo¥vJlord ol Part 15 C(W185 Att 2Iy)6 afe ( thwlilknn to the rrornbers o111* comp￿¥ Th¢ •t p•4u 23 to 37 lorni ptrt ot thHt •r¢ourt atecruAts w•r* 4pprw•d the BD•rd olTrustr*s on 17 ju￿1 1025 21 NATKJN41 RMEUMA7010 AmlRm5 5QCIErY CQI45QUDATED 5TATEMEtn OF CASH FLQW5 FOR THEYEAR ENDEO Ji fKcEMbER Gmup Charity ZQ24 2023 2024 2013 Cash froth opqTrilrn¥ Cash l￿d kn ¢per•iDQhS 19LS 358.0 194,1 359.6 In¥qstJni Purch15e of InT3ll8lble firfvd •ss•t5 Purcha￿Of tarwblÈ flxed asse Purchaseof 115ted Investfwlts Pwth)S* of short twrn trrf¥*StM¢nt% Interest reEviwed 0.0 (6.21 (32.3J (261,5) .0 14.01 0.0 16_2 132.31 1261.51 59.1 ,0 14.01 13Q,21 Net <•sh in In¥qstlni artl¥l¢deg 1240.91 {24Q.91 Net decfeast In rash and c•5h equlv•len 149.4J 3585 1468 C3th W•d e•sh equi¥aleTrts at becSnfilns olyew 667.4 C•sh 4Trd t*sh ¢wlv•l•nts at •Thd of ye•r 618.0 667.4 617.6 661A 22 IIA TKIMAL RHEu￿TOlD ARTHRms SOCErY i•trTES TO THE A¢C¢UNrs FOR T￿ YUR ÉhtsÈO 31 DECEM8ER 2fy21 MatlMBI Rhè￿￿1•1￿ Arilw*s $¢x￿ty IS & prkalè by ID Chartsts and Tr4¥fw Intrwlrr*rnl ISo)w th12CQS. lh• CbarA*8 Atojthlx R•]Wat]￿B 2[￿[0* 4m&rbl&gl WLI "kn￿rry by Cl￿r￿S ol RK¢mrntndtd Prnfjbw lo cAurrth& I￿￿•1￿ Iher in w4h R•pwbrvJ SiwHlwKI •ppl*ablè UK 4nd A•wl*c ot IMl8rAY {FRS 102r. 4 Bv*lrt Entrty ** d￿l¥ll ty FRS 1ryi ar• IL> the rc FwpBrtDès t*> IncibJ• I￿1￿j fi¥￿￿18 arbj tsrtafft at l•ir v•hJ¢ Tr prw41 ac•xwbry PJI Prnpirllbon •1 G•n•trlIdal￿ fiwnchl slat•ffl•Trts Th•M Gonwha•t•d staiemrthls [man￿1 itsterr*nts ol liw Chanty aThJ Il& Mdert•kiw, NRAS C￿tsn1ty Lyftrled. vp 19 3108¢4mbef 2Q24 thterwnwrry tran8K#mo. balJrKes l￿d UNt￿l￿d gm Ihe Clwrty rts •re eIn￿*d ol Jth*lL•ry undert•kU￿ hav• dwr47gd rt•c•88•ry la •nsur* *llh I￿ pok•* adopl•J by th• Gtwp. Thi ir￿c￿￿• of IlK• At th• ljmrj of apprw¥y ac£9nl￿J 4Ytt IM b•oD ￿1)1￿ & the rblfijs ￿rfo￿￿T￿l reguiM d￿e￿al pl fv ¥rnounL InccfThÈ r*tovw*Jl• ￿ I￿￿1￿ ID 1¢￿1hxw Mekn*d urf•r 23 NATI0p￿ RHEUMATOID ARThRrrig SocErY P40FESTL) THEACCOUP4TS FDR T￿E YWI ENDEts 31 DECElJl&ER 2fy24 krw, 4FHI rec•pl il Thunl knfrhfi. th• trealqd al Vd fth15iWI ass ThB <*arty QMnf¥ ffj T•¥>￿t ol &divilivs lh• £￿￿ty. lfictft* Inm w¥nlS w• r￿n￿•S ￿lI1r 4r& tht ch*r*y •nIrtlofn￿t aéler any PtrtNm¥K• ha¥t tthl Il 0 I￿[￿*1• I￿11￿ inxn• ￿11 bt ￿l¥¥j arity. f*C*•wd in IDf 1UPP￿*1￿ &vx¥J¥ ¥•r¥K•s r ottlef Its WKI whrb 0•1￿*• ytr¥ided nwnAI Iwsiws*. n•1 Old￿Coun1￿ VA T •nd ¢ther rf•1•d Eax•s. IA It••wrf•• •xp•vthd •%p•fvfthr• 1$ lor oft •ft *ttnAl* bm• Iw• ba•n ¢1oW*O urthr 11￿1 49feg4* •1 coèls rnl•lKI Eg thTr ¢•fpwry wh•r• Is 8 *al at1w1*￿ lo mak• p4ymertt$ 10 paths. cib*ly Ihal tho MI￿¢*nI *•ll b• r•4wwI •bWIl abthg•bw 1>• Th*41ur*O t*llabty. * i¥ ¢4LpJrywg urbJ•f Ih rolthvlr¥ )Yw18•• 8). rK4)vèr•blg VAT h chwwl •• •A •>p•fiM •9wthI Il* •cbwty *dIr￿ls￿￿T￿l ¢0¥• They ¥e M ncurr•d dirncty lutherry Of1￿ m•J• tor Ilw)fj• costs rel•l#)g ta th• r•l•ry of Ivvth lo gevwnw¢•. Tl* bBJ•I on <¢fv*B bmn &le*atèd *•1 wt h) N¢* •. FuTrar•i#rrry •r• 5hthd In tlote 7. E)P¥nth￿ ￿ ￿cl￿nt*d for orn •n baw8 haj been wNJ•r * Ihat wrtgalt rfit•d tq 24 NATlOrtAL RHEUhlATOID ARTHRtns $(KEtY NDTES Tts Tr4E Accoufff3 FCIR THE VE4R ENDED 11 DECEMBER Z024 ￿tt￿rrtI￿ PDle*• In 4.8 Inurylblv •￿1 l•nBhbh taN•d 21PA itrtr)M IM pwhxl * sl 25% 1tr&¥)ht I 25% strltphl kne FrA1LLtts. & equi￿1 Tmlw ol thè an￿1 ly roCOgnW kn T￿1 thctyrrfw•￿lllur•> y•w. 1.7 Imp•lrmw* of fix•d ropw ei¥J d•ie. the tharity rtr•*WS carryww rfs t4r4ibl• •5¥ts ty d*lt¢rnine Wl￿1héff Ilw wwjicalw Ihtsl thos• 8sws svif¢red ￿ ffipoiffrlent h)s8. Il iTraKalKin wxts, th¢ reojyorablo arn￿￿1 45s•11s •slThTt•LI ITr k* èll￿1 ol Ihtr •MPaifftWIl {K any). l.• C•¥h •rxl c•sh •4ufr¥alw cosfft IrK&J¢p c*¥ft In h4￿J. dwills hok14l ull tr￿ks, 4th•1 $￿n.1•rn IJY•*sblWJfits t)r¥ml rn•t￿ts￿ ol thrw or 1•>3. •nd b•nk ovtsdrafts. Bwk Ovwdw4ft• •ro vrflyn t)orr•tyiNJJ n tufgtni 1.9 short E•m In¥••tm•nl• ••r. 1.10 lrntrum•rt¥ Tha hay elected t<> ¥ply pro¥isvis ol S¢ckn 11 Bast F¥￿ddI IMinllYwl•' and S•dkn 12 frw*? lh• h￿IruMO￿L Finarwl *sJtsts and li•l>tlrtth w• off¥eL •wJnu firw￿la1 slBlerngrfs, i¥ • gnfort*abl& io oll tm wvj • •n to Uillle oft a n•1 th• •Thy kètdrty sIMultar*￿Sty 5bipJiys • irws*hoft. whère I1￿ prwnl ol Ihe I￿11? focW5 4t r41• ¢Jl IT*wrg*. Fin•rwI *ssètB dassme￿ •B *liiw amortm 25 MA TIOMAL RHELIAIATOID ARThRms 50CI l¢OTE3 TO THE A¢￿U￿r5 FOR THE YEAR ENDED 31 DECEMBER XI24 BBait hblrtw. Inckkybig erKlits5 4fKI b￿k loo￿ Inib•ty unt￿& • rnwk•l of *)¥tèsi pay4b* tYO nLI Tr*d• crttlrtor* ar• pay lor s¢rvw 1141 boon •C4ukn•d in th• ¢)pMt&￿l frgffl SUFpl4ir¥. AMI￿n￿ P¥rf4blp Jr• clas4i&d ¥ ew*tsl Wil0*6 Il Payrnenl is duv withkn lèw If rkoc I￿Y pr*5th7Ied as non*rurr•nl la￿1￿*6. Tfioe rr•diw5 4r• tnnuckn pr*è 4r41 AI 1.11 Flx•d lryw••lrnfrfftl• •9901 ffj¥•5frnntB Arè tsitlavy rn6•wr•d at Iwi8&ebM pK• •¥cI￿ling tran8a¢tsrt &)d4s. at• subs•]￿ntrY mo8wr•d •1 lair v•bJo ￿ •ach I￿￿r￿a Chanw are wr4•d I1wnWI•XF￿VJ{•) for N ￿. TMr04C>2n 1.12 b•n•llts Th* •Ay holKl•y •nbllwMnl is th• got￿ kn tathith •ef¥th rn¢¢fv*J. •M¢tyMrrts 01 •n ampkny•• or ¢0 IvrniTral￿ benef*s. l.lj L•u•• pay*lo urrfl•r oper*bry knKSJ• iry IM•••K•nty•W• f•cthYd, •1• ¢th•rs•g +)n 4 ba rtr ol ihe 2 Crtiicol •cec+unfjrnL4 Mllmat•i Judp•rn&Thts 4rAiirryknRs •ttyyJI ￿￿y11¥ wrtsJN fA ass•l$ I￿j ilal nol r•WI aH)wtThl freth tAl￿r scwrr•5. Th •rbJ ass￿1￿1•d a55￿p1￿* att ba*d on hlstml aril olt•r14c*n th•1 cmthf•d r•*vafflL AthAI rèsults m•y drflw frtyn IP*e •>lm•t•¥. i•coirwd ITr tho in *fib¢h ••kniale IJ revi￿d *t•r• ltr￿ *Yecls ffjty 9•rnd, ol lh• TIO*IAL RHEVMV4TOID mRITIS SOCETY r•DTE5 TO TMÉ AttDLIMTS FCA? TME YEIR EI¥DED 31 DECEMBER 2ts24 453A 788.7 561,5 JXI40A 1,242_1 PAs¢r*red IwrKfs .141 7 1342.1 LfoJl.9 4 Pft¢thknè thwl¢•bl• acllvlli fyoup th*ity 23.3 16.0 105.3 217 29.2 716 Ilesefjrth Sluthes GrarWJ 115.9 210,9 Nèitrtt•d fur¥l¥ 4a7 J62.2 Zlthg 191_3 125.J S Ixher Xt1￿ G*tyJg •ffld ¢hrfty 2QI4 202> t¢rthrth 4nd tr4dlr4VlfCffi 14S IP.5 4fpJ 2024 Kryro from Ilfftd Irrtstrr*r knrET¢rt irKorn 30.2 IIt>TE5 TD 714 AryQUhTS Ftm THE WA Iwtsltr •I tsÉCÉMBER (hwb 1024 7A 42 iTr.J 117.9 Il.J Il J 123 &2 1*0 J31A 1245 574 i)io 133.4 J4 2dl 293 1)17 73 *IY>.7 ol x¥wt cosrj iw• r41M YJ 2Y12 1>4 OfJ Ji &7 41SI 14J 1r¢i*d 3).4 301.9 00 OD 2419 to. 49. LJ32 2 j.iiij 14LA FOR T￿E IVOAO 2014 7A 242 17.9 275A oo 12.3 ui YYA 13.5 424.5 s?.4 77A aB¢J J37.U .233A 10>.7 ri evk E d gjpm COSts 9> 612 0£4 191.9 1119 39 2Y7 1S.4 tso 134 13.4 h%9 iisj Lk J119 415,3 745 2149 uii 5tsNusts %s Crflbt* 1711 22.1 2fkS 41 Si.? IrrEcurfr*¥AT 24.1 71ffj 51.7 17J 170 JJ 571.2 •36 $19 .J IJA 46* rty 2Wi JJ 303 97] 3&5 3rk5 17 24.> Irr¢¢ryhYr•b* VAI 41. 51.7 SL7 Insur￿• 64 17J 17,3 t7JJ CAO 124 ssa •1 Fw&traI￿n1 Inore 113 i) 46.9 2842 JVA2 orts TO ThE ACCOUNTS FOR ThE YWÉ ENOED31 DEtthlkR 1014 11 EMpltyt*s Mumb*r Thl •VEf¥e mtrnthty oltnwtQYW5 the All emL*yffeJ. Grw and Chorrty 30 30 The a¥rr4Ke numbwd I￿$.t}me¢qU￿knI 0fflpkw￿duf￿￿ yelf *41., l ernplU￿5- 6ft)up Chirity 26 Group charty 1023 1023 Wate$ 4r*d J*l*l¢s S¢csil securily 936,1 910,6 46.8 78.1 936.1 46.7 85.9 1.068.7 910.6 46 78.1 1,035 1,068.7 The t4xal DI reOwthrKY P￿rne￿5 mède by the C4xnp•ny in th¢ywr w45 £1.346121)23'. ￿.1￿) lkn number ol empltyées who r¢ceYv•d 1014 ernp*e benefits (e*cl¥dlry¢fflplry¥tr wniiw cos1$1 ol more thJTr E60.IJKI is s follo4￿. Plwib £70m. £80.4 R•muTw4ilw ol ke¥ fflDwerMnt p•rsowil Thq rornbJnw4lron 0¢ key rMrt•6wwni p￿5￿nF￿1 ts a5 loll0￿.. 14).4 184.9 Ji IIATiofiAL 4vrHR11155EO 311)ÉCÉh*kÉA 2Q24 J6 n15 *•lllw &J• ?,0 17,7 0.0 337.5 i?,y Ammtj tr•rnl try BwunL*rtakiry5 75,4 JJ?.s 48 46 40 drtfl4x3 Irxlude E25.3k felèiiry tErrn thL1ry5 rK¥vable lft Wterth￿ ¥￿$ Ch￿ty 20Z4 Z013 2024 2023 T[￿+ crtdrt Other wclll $￿￿rtty ¢osts Is.¥ 17.7 SS.7 7A iu 17.7 55,T 25 44.2 33_1 12S.2 •7A 114.7 1024 DelerrEd kncc¥r* the dbwKlal ststements•i 101104¥S: l J JIM￿ry 14to¥em•nt dur1￿ IhE ye•ff 131 Oe¢ember [3.& 13.8 11 H•ik•rnMI b•n•fii Jthom Jtherns The Clhty owr•t•s I ￿hètht lor I114wMyln4 The 05*ts Icthe￿ thiryÈ its loss ol dofjned.4 618.0 Tot•1 667.4 {49.41 61&0 37